Literature DB >> 16991175

Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium.

Kai Temming1, Marie Lacombe, Roel Q J Schaapveld, László Orfi, Gyorgy Kéri, Klaas Poelstra, Grietje Molema, Robbert J Kok.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16991175     DOI: 10.1002/cmdc.200600201

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  13 in total

1.  Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Authors:  Ming-Hsin Li; Seok Ki Choi; Thommey P Thomas; Ankur Desai; Kyung-Hoon Lee; Alina Kotlyar; Mark M Banaszak Holl; James R Baker
Journal:  Eur J Med Chem       Date:  2011-11-23       Impact factor: 6.514

2.  Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.

Authors:  Thommey P Thomas; Melvin Joice; Madhuresh Sumit; Justin E Silpe; Alina Kotlyar; Sophia Bharathi; Jolanta Kukowska-Latallo; James R Baker; Seok Ki Choi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

3.  Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.

Authors:  Amanda B Witte; Christine M Timmer; Jeremy J Gam; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  Biomacromolecules       Date:  2012-01-18       Impact factor: 6.988

4.  Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery.

Authors:  Thommey P Thomas; Seok Ki Choi; Ming-Hsin Li; Alina Kotlyar; James R Baker
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

5.  Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.

Authors:  Justin E Silpe; Madhuresh Sumit; Thommey P Thomas; Baohua Huang; Alina Kotlyar; Mallory A van Dongen; Mark M Banaszak Holl; Bradford G Orr; Seok Ki Choi
Journal:  ACS Chem Biol       Date:  2013-07-26       Impact factor: 5.100

Review 6.  Co-opting biology to deliver drugs.

Authors:  Parisa Yousefpour; Ashutosh Chilkoti
Journal:  Biotechnol Bioeng       Date:  2014-07-21       Impact factor: 4.530

7.  Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury.

Authors:  Jai Prakash; Martin H de Borst; Marie Lacombe; Frank Opdam; Pieter A Klok; Harry van Goor; Dirk K F Meijer; Frits Moolenaar; Klaas Poelstra; Robbert J Kok
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

8.  Integrin targeted delivery of chemotherapeutics.

Authors:  Kai Chen; Xiaoyuan Chen
Journal:  Theranostics       Date:  2011-02-17       Impact factor: 11.556

9.  Biomolecular interaction study of Cyclolinopeptide A with human serum albumin.

Authors:  Ben Rempel; Bo Gui; Jason Maley; Martin Reaney; Ramaswami Sammynaiken
Journal:  J Biomed Biotechnol       Date:  2011-03-10

10.  Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells.

Authors:  M E M Dolman; Stefan Harmsen; Ebel H E Pieters; Rolf W Sparidans; Marie Lacombe; Bálint Szokol; László Orfi; György Kéri; Gert Storm; Wim E Hennink; Robbert J Kok
Journal:  Int J Nanomedicine       Date:  2012-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.